Ginkgo Bioworks Holdings, Inc.DNANYSE

Revenue (LTM)

$170M

-25.1% YoY

Net Income (LTM)

$-313M

+42.8% YoY

Free Cash Flow

$-179M

Revenue CAGR (5Y)

+17.3%

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	314	478↑52.2%	251↓47.4%	227↓9.7%	170↓25.1%
Gross Profit	184	273↑48.5%	197↓27.8%	188↓4.5%	139↓26.5%
Operating Income	-1,828	-2,209↓20.8%	-864↑60.9%	-560↑35.2%	-315↑43.7%
Net Income	-1,830	-2,105↓15.0%	-893↑57.6%	-547↑38.7%	-313↑42.8%
EBITDA	-1,807	-2,060↓14.0%	-821↑60.1%	-484↑41.0%	-255↑47.4%
EPS Diluted	-55.53	-50.20↑9.6%	-18.40↑63.3%	-10.54↑42.7%	-5.64↑46.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	1,550	1,316↓15.1%	944↓28.3%	562↓40.5%	167↓70.2%
Total Current Assets	1,723	1,450↓15.8%	1,002↓30.9%	603↓39.8%	472↓21.7%
Total Assets	2,071	2,539↑22.6%	1,665↓34.4%	1,377↓17.3%	1,120↓18.7%
Total Current Liabilities	135	173↑28.3%	164↓5.3%	107↓34.5%	96↓10.5%
Total Liabilities	504	803↑59.5%	568↓29.2%	661↑16.4%	611↓7.6%
Total Equity	1,505	1,736↑15.3%	1,097↓36.8%	716↓34.7%	509↓29.0%
Total Debt	23	443↑1821.8%	239↓45.9%	468↑95.5%	417↓10.8%
Net Debt	-1,527	-873↑42.8%	-705↑19.3%	-94↑86.7%	250↑366.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-254	-252↑0.6%	-296↓17.2%	-320↓8.2%	-171↑46.5%
Capital Expenditure	-57	-52↑7.5%	-41↑21.9%	-63↓53.3%	-8↑87.7%
Free Cash Flow	-310	-304↑1.9%	-336↓10.5%	-382↓13.6%	-179↑53.2%
Stock-Based Comp	1,606	1,931↑20.2%	230↓88.1%	112↓51.1%	82↓27.4%
Net Change in Cash	1,207	-223↓118.5%	-380↓70.1%	-384↓1.0%	-393↓2.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance